A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Latest Information Update: 29 Mar 2024
At a glance
- Drugs Indoximod (Primary) ; Temozolomide
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors NewLink Genetics Corporation
- 19 Aug 2019 Status changed from active, no longer recruiting to completed.
- 17 Apr 2019 Planned End Date changed from 1 Oct 2018 to 29 May 2019.
- 02 Jul 2018 Status changed from recruiting to active, no longer recruiting.